HK1205510A1 - Indolopyridines as eg5 kinesin modulators eg5 - Google Patents

Indolopyridines as eg5 kinesin modulators eg5

Info

Publication number
HK1205510A1
HK1205510A1 HK15106078.5A HK15106078A HK1205510A1 HK 1205510 A1 HK1205510 A1 HK 1205510A1 HK 15106078 A HK15106078 A HK 15106078A HK 1205510 A1 HK1205510 A1 HK 1205510A1
Authority
HK
Hong Kong
Prior art keywords
indolopyridines
kinesin modulators
kinesin
modulators
Prior art date
Application number
HK15106078.5A
Other languages
English (en)
Chinese (zh)
Inventor
Matthias Vennemann
Thomas Br
Jrgen Braunger
Astrid Zimmermann
Volker Gekeler
Original Assignee
4Sc Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 4Sc Ag filed Critical 4Sc Ag
Publication of HK1205510A1 publication Critical patent/HK1205510A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15106078.5A 2006-02-22 2015-06-25 Indolopyridines as eg5 kinesin modulators eg5 HK1205510A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06110295 2006-02-22
EP06119038 2006-08-16
EP07704690.2A EP1996592B1 (en) 2006-02-22 2007-02-21 INDOLOPYRIDINES AS MODULATORS OF KINSIN EG5
EP14180089.6A EP2824105B1 (en) 2006-02-22 2007-02-21 Indolopyridines as Eg5 kinesin modulators

Publications (1)

Publication Number Publication Date
HK1205510A1 true HK1205510A1 (en) 2015-12-18

Family

ID=37964159

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106078.5A HK1205510A1 (en) 2006-02-22 2015-06-25 Indolopyridines as eg5 kinesin modulators eg5

Country Status (18)

Country Link
US (1) US8530493B2 (ja)
EP (3) EP2824105B1 (ja)
JP (1) JP5349056B2 (ja)
KR (1) KR101415354B1 (ja)
CN (1) CN101389628B (ja)
AR (1) AR059609A1 (ja)
AU (1) AU2007217560B2 (ja)
BR (1) BRPI0708233A2 (ja)
CA (1) CA2643488C (ja)
EA (1) EA015150B1 (ja)
HK (1) HK1205510A1 (ja)
IL (1) IL193625A (ja)
MX (1) MX2008010801A (ja)
NZ (1) NZ571357A (ja)
TW (1) TWI377207B (ja)
UA (1) UA96592C2 (ja)
WO (1) WO2007096393A1 (ja)
ZA (1) ZA200808070B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ATE556713T1 (de) 1999-01-13 2012-05-15 Bayer Healthcare Llc Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
AU2003209116A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Aryl ureas with angiogenesis inhibiting activity
PT1636585E (pt) 2003-05-20 2008-03-27 Bayer Pharmaceuticals Corp Diarilureias com actividade inibidora de cinase
US20050192356A1 (en) * 2004-02-27 2005-09-01 Babish John G. Synergistic anti-inflammatory pharmaceutical compositions and methods of use
EP1751139B1 (en) 2004-04-30 2011-07-27 Bayer HealthCare LLC Substituted pyrazolyl urea derivatives useful in the treatment of cancer
JP2008509971A (ja) 2004-08-18 2008-04-03 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｅｇ５キネシンのインヒビターとして使用するためのベンゾチエノピリジン
EP1855760A2 (en) 2005-02-03 2007-11-21 TopoTarget UK Limited Combination therapies using hdac inhibitors
KR101329437B1 (ko) * 2005-05-13 2013-11-14 토포타겟 유케이 리미티드 Ｈｄａｃ 억제제의 약학 제형
EP2361619A1 (en) 2005-11-10 2011-08-31 TopoTarget UK Limited Histone deacetylase (hdac) inhibitors (pxd-101) alone for the treatment of hematological cancer
EP2033962A1 (en) * 2007-08-22 2009-03-11 4Sc Ag Tetracyclic indolopyridines as EG5 inhibitors
EP2203421B1 (en) * 2007-09-25 2014-05-07 TopoTarget UK Limited Methods of synthesis of certain n-hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide compounds
EP2098524A1 (en) * 2008-03-05 2009-09-09 4Sc Ag Process for preparing enantiomerically pure indolopyrinidines
CN102083428A (zh) * 2008-03-07 2011-06-01 顶标公司 采用长时间连续输液Belinostat进行治疗的方法
GB0900555D0 (en) * 2009-01-14 2009-02-11 Topotarget As New methods
CN109467555A (zh) * 2018-06-21 2019-03-15 广东蓝堡生物科技有限公司 一种他达那非衍生物及其制备方法和应用
CN109160914B (zh) * 2018-11-17 2020-06-16 重庆文理学院 一种双吲哚并吡啶类衍生物的合成方法及在抗肿瘤中的应用
CN111529526B (zh) * 2020-04-14 2021-04-23 广州领晟医疗科技有限公司 一种化合物在制备治疗急性胰腺炎的药物中的用途
CN113577063B (zh) * 2021-08-30 2022-08-16 广州领晟医疗科技有限公司 一种化合物在制备治疗炎性肠病的药物中的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357122A3 (en) 1988-08-29 1991-10-23 Duphar International Research B.V Use of beta-carbolines, their bio-isosteric benzofuran and benzothiophene analogues for the manufacture of a medicament having cytostatic properties
GB9514473D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
DE19744257B4 (de) 1997-10-07 2004-04-15 Zentaris Gmbh Beta-Carboline und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen
US6890933B1 (en) 2000-02-24 2005-05-10 President And Fellows Of Harvard College Kinesin inhibitors
MXPA03002911A (es) 2000-10-03 2003-09-10 Lilly Icos Llc Compuestos quimicos.
AU2002310099A1 (en) 2001-05-22 2002-12-03 President And Fellows Of Harvard College Identification of anti-protozoal agents
WO2003024936A1 (en) 2001-09-19 2003-03-27 Pharmacia Corporation Substituted pyrazolo compounds for the treatment of inflammation
EP1474420B1 (en) 2002-02-01 2012-03-14 AstraZeneca AB Quinazoline compounds
AU2003247891A1 (en) 2002-07-08 2004-01-23 Merck & Co., Inc. Mitotic kinesin binding site
US7022850B2 (en) 2003-05-22 2006-04-04 Bristol-Myers Squibb Co. Bicyclicpyrimidones and their use to treat diseases
WO2004111193A2 (en) 2003-06-12 2004-12-23 Merck & Co., Inc. Prodrugs of mitotic kinesin inhibitors
US8940896B2 (en) 2004-03-15 2015-01-27 Ptc Therapeutics, Inc. Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis
JP2008509971A (ja) * 2004-08-18 2008-04-03 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｅｇ５キネシンのインヒビターとして使用するためのベンゾチエノピリジン
AU2006212863A1 (en) 2005-02-10 2006-08-17 Merck Sharp & Dohme Corp. Mitotic kinesin inhibitors
WO2007144384A1 (en) 2006-06-14 2007-12-21 4Sc Ag Pyrazolopyrimidones
EP2041141A2 (en) 2006-07-13 2009-04-01 4Sc Ag Benzopyranopyrazoles

Also Published As

Publication number Publication date
TWI377207B (en) 2012-11-21
KR101415354B1 (ko) 2014-07-04
IL193625A (en) 2015-01-29
AR059609A1 (es) 2008-04-16
CA2643488C (en) 2014-08-05
JP5349056B2 (ja) 2013-11-20
EP3862354A1 (en) 2021-08-11
EP2824105A1 (en) 2015-01-14
UA96592C2 (uk) 2011-11-25
EP2824105B1 (en) 2021-03-31
BRPI0708233A2 (pt) 2011-05-24
AU2007217560B2 (en) 2012-06-28
ZA200808070B (en) 2014-03-26
NZ571357A (en) 2010-11-26
JP2009527533A (ja) 2009-07-30
KR20080098043A (ko) 2008-11-06
CN101389628A (zh) 2009-03-18
MX2008010801A (es) 2008-09-05
TW200815441A (en) 2008-04-01
EA015150B1 (ru) 2011-06-30
EP1996592A1 (en) 2008-12-03
CN101389628B (zh) 2013-02-27
WO2007096393A1 (en) 2007-08-30
IL193625A0 (en) 2009-05-04
AU2007217560A1 (en) 2007-08-30
EA200801739A1 (ru) 2009-04-28
CA2643488A1 (en) 2007-08-30
EP1996592B1 (en) 2014-08-27
US20090233902A1 (en) 2009-09-17
US8530493B2 (en) 2013-09-10

Similar Documents

Publication Publication Date Title
HK1205510A1 (en) Indolopyridines as eg5 kinesin modulators eg5
IL193624A0 (en) Indolopyridines as eg5 kinesin modulators
GB2438204B (en) Gabions
EP2050881A4 (en) ARROW
IL193176A0 (en) Benzoyl-piperidine derivatives as 5ht2/d3 modulators
GB0709295D0 (en) New Zealander
EP1979825A4 (en) MANAGING RELATIONS WITH XNA
GB2434352B (en) Winch
IL179202A0 (en) Secure communication
ZA200806810B (en) Benzoyl-piperidine derivatives as 5HT2/D3 modulators
GB0714775D0 (en) Gum
IL195529A0 (en) New crystal forms
GB0619875D0 (en) Gum saver
AU2007901161A0 (en) Anchor
AU2008101204A4 (en) Effective Rate
AU2007901627A0 (en) Improved anchor
IL180819A0 (en) Intencity breaking indcator
AU2008903609A0 (en) TCP - The concrete protector
AU2006903488A0 (en) Anchor
GB0618744D0 (en) Hydraulic benchvice
AU2008903857A0 (en) Modulator
AU2007906024A0 (en) Winches
AU2008903326A0 (en) A pier
AU309101S (en) Shackle
GB0606408D0 (en) Gabions